Percutaneous vertebroplasty improves pain and quality of life in patients with VCF .
This report has been verified
by one or more authors of the
original publication.
Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures
J Neurosurg Spine. 2011 May;14(5):561-9. doi: 10.3171/2010.12.SPINE10286. Epub 2011 Mar 482 patients with vertebral compression fractures (VCF) were randomized to either percutaneous vertebroplasty (PV) or optimal medical therapy (OMT) to compare their efficacy in improving pain and quality of life (QOL). Percutaneous vertebroplasty led to a short-term (6 months) improvement in pain and long-term (36 months) improvement in QOL when compared to optimal medical therapy. Thus, this study considered percutaneous vertebroplasty to be more effective in patients with acute VCF than optimal medical therapy. Further research should be undertaken to compare vertebroplasty to other operative options.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
